Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2010 | 09-2010 | 07-2010 | 06-2010 | 04-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 873 | N/A | 908 | N/A | 633 |
| Receivables | 1,789 | N/A | 3,537 | N/A | 934 |
| Inventories | 246 | N/A | 273 | N/A | 325 |
| TOTAL | $2,984 | $N/A | $4,786 | $N/A | $2,001 |
| Non-Current Assets | |||||
| PPE Net | 163 | N/A | 164 | N/A | 164 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 69 |
| TOTAL | $163 | $N/A | $164 | $N/A | $233 |
| Total Assets | $3,147 | $N/A | $4,950 | $N/A | $2,234 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 836 | 0 | 1,336 | 0 | 491 |
| Accrued Expenses | 727 | N/A | 939 | N/A | 1,016 |
| TOTAL | $1,563 | $N/A | $2,275 | $N/A | $1,508 |
| Non-Current Liabilities | |||||
| TOTAL | $61 | $N/A | $66 | $N/A | $71 |
| Total Liabilities | $1,624 | $N/A | $2,341 | $N/A | $1,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,825 | N/A | N/A | N/A | 11,596 |
| Common Shares | 138 | N/A | 138 | N/A | 113 |
| Retained earnings | -41,565 | N/A | -40,470 | N/A | -40,002 |
| Other shareholders' equity | -564 | 0 | -564 | 0 | 0 |
| TOTAL | $1,523 | $N/A | $2,609 | $N/A | $656 |
| Total Liabilities And Equity | $3,147 | $0 | $4,950 | $0 | $2,234 |